Kwality Pharmaceuticals receives approval from INVIMA for Ampoule and Vial product lines
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
The company has reported total income of Rs. 70.59 crores during the period ended June 30, 2022.
Subscribe To Our Newsletter & Stay Updated